Both Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology ...
6046 items (6046 unread) in 74 feeds
Both Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Sierra Oncology Inc. (NASDAQ:SRRA) are each other's competitor in the Biotechnology industry.
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Entera Bio Ltd. (NASDAQ:ENTX), both competing one another are Biotechnology companies. We will ...
Cui Global Inc (NASDAQ:CUI) institutional sentiment increased to 1.15 in 2018 Q3. Its up 0.08, from 1.07 in 2018Q2. The ratio is more positive, as 15 hedge ...
The Angiosarcomas Treatment Market Research Report 2019 examines the competitive landscape , Market dynamic and discusses major trends. The report ...
Analysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
This is therefore a contrasting of the dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation in NuCana plc.
Renaissance Technologies LLC increased its position in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 12.3% in the 3rd quarter, according to its most ...
On February, 27 WallStreet anticipated TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings release, Faxor reports. Analysts have anticipation on stock's ...
Pacific Biosciences of California Inc. (NASDAQ:PACB) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology ...
This is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Caladrius Biosciences Inc. (NASDAQ:CLBS) based on their institutional ...
As Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), are affected by contrast.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report is expected on February, 27., Faxor reports. Analysts have anticipation on stock's earnings ...
Analysts expect Core-Mark Holding Company, Inc. (NASDAQ:CORE) to report $0.30 EPS on March, 7.They anticipate $0.03 EPS change or 9.09% from last ...
During 2018 Q3 the big money sentiment increased to 1.15. That's change of 0.08, from 2018Q2's 1.07. 5 investors sold all, 8 reduced holdings as CUI Global,
Analysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
Tracon Pharmaceuticals Inc (NASDAQ:TCON) had a decrease of its short interest by 6.73%. It was published in February by FINRA the 134400 short interest on.
As Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), are affected by ...
We will be contrasting the differences between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and SELLAS Life Sciences Group Inc. (NASDAQ:SLS) as far as ...
As Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Therapix Biosciences Ltd. (NASDAQ:TRPX), are affected by contrast.
During 2018 Q3 the big money sentiment increased to 1.15. That's change of 0.08, from 2018Q2's 1.07. 5 investors sold all, 8 reduced holdings as CUI Global,
The major companies in Orphan Drugs Industry include AbbVie Inc., Aegerion Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Celgene Corporation, ...
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) compete with each other in the Biotechnology sector. We will ...
On February, 27 TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report is awaited by WallStreet, as reported by RTT. The EPS diference is $0.01 or ...
During Q3 2018 the big money sentiment increased to 1.15. That's change of 0.08, from 2018Q2's 1.07. 5 investors sold all, 8 reduced holdings as CUI Global,
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kadmon Holdings Inc. (NYSE:KDMN) are two firms in the Biotechnology that compete against each other.
This is a contrast between Seres Therapeutics Inc. (NASDAQ:MCRB) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) based on their analyst ...
The Angiosarcomas Treatment Market is expected to have a highly positive outlook for the next five years 2018-2026 according to a recently released ...
Analysts expect Teladoc Health, Inc. (NYSE:TDOC) to report $-0.35 EPS on February, 26.They anticipate $0.15 EPS change or 30.00% from last quarter's $-0.5 ...
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and OvaScience Inc. (NASDAQ:OVAS) have been rivals in the Biotechnology for quite some time. Below is a ...
As we sat at the intersection of Washington and Faculty road in Princeton, New Jersey, my friend Jacob said, “You know you can make a right turn at a red light.”.
Analysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
Renaissance Technologies LLC grew its holdings in shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 12.3% during the third quarter, according to ...
Analysts expect Solar Senior Capital Ltd. (NASDAQ:SUNS) to report $0.33 EPS on February, 21 after the close.They anticipate $0.02 EPS change or 5.71% from ...
Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) were up 10.6% on Friday . The company traded as high as $0.95 and last traded at $0.94.
Shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) were up 10.6% on Friday . The company traded as high as $0.95 and last traded at $0.94.
This is therefore a comparing of the risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation in TRACON.
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Curis Inc. (NASDAQ:CRIS) are Biotechnology companies, competing one another. We will compare ...
We are contrasting Arbutus Biopharma Corporation (NASDAQ:ABUS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) on their institutional ownership, ...
It was reported a decrease on Athenex Inc (NASDAQ:ATNX)'s shorted shares with 3.81%. In February was announced ATNX's total 4.08M shorted shares by ...
It was reported a decrease on Athenex Inc (NASDAQ:ATNX)'s short interest with 3.81%. In February was issued ATNX's total 4.08 million short interest by FINRA.
In January, Union Finance Minister Arun Jaitley left for the United States just before the crucial budget session. Despite concerns about his health and the ...
On February, 27 WallStreet awaited TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report, according to Zacks. Analysts forecast 2.70 % diference ...
TRACON Pharmaceuticals Inc (NASDAQ:TCON)'s share price rose 10.6% on Friday . The stock traded as high as $0.95 and last traded at $0.94. Approximately ...
In October, James P. Allison and Tasuku Honjo won the Nobel Prize in medicine for their groundbreaking cancer research.
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings report is expected by WallStreet on February, 27, as reported by RTT. Analysts expect change of ...
Tracon Pharmaceuticals Inc (NASDAQ:TCON) recorded a decrease of 6.73% in short interest. FINRA published in January TCON's total 134400 short interest.
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Ritter Pharmaceuticals Inc. (NASDAQ:RTTR), both competing one another are Biotechnology companies.
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and AnaptysBio Inc. (NASDAQ:ANAB) compete on a level playing field in the Biotechnology industry.
Kindred Biosciences Inc. (NASDAQ:KIN) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete with each other in the Biotechnology sector. We will ...
(MENAFN - EIN) The Sarcoma Coalition was launched as collaboration of sarcoma advocacy organizations. Because of the rarity of this cancer, many people ...
The risk of developing angiosarcoma following radiotherapy for breast cancer is low but present, and it should be treated at least with surgery, say Dutch ...
The stock of GDS Holdings Limited (NASDAQ:GDS) is a huge mover today! The stock increased 5.29% or $1.35 during the last trading session, reaching $26.85.
Global Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016-2022. Orphan ...
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Tiziana Life Sciences PLC (NASDAQ:TLSA) have been rivals in the Biotechnology for quite some time.
aTyr Pharma Inc. (NASDAQ:LIFE) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are two firms in the Biotechnology that compete against each other.
Both Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete on a level playing field in the ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Sangamo Therapeutics Inc. (NASDAQ:SGMO) are each other's competitor in the Biotechnology ...
Analysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Cellular Biomedicine Group Inc. (NASDAQ:CBMG) compete on a level playing field in the ...
On February, 27 WallStreet anticipated TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)'s earnings release, according to Zacks. This year's EPS analyst ...
Renaissance Technologies LLC increased its holdings in TRACON Pharmaceuticals Inc (NASDAQ:TCON) by 12.3% in the 3rd quarter, according to its most ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Zealand Pharma A/S (NASDAQ:ZEAL) are Biotechnology companies, competing one another.
TRACON Pharmaceuticals (NASDAQ:TCON) and BioCardia (OTCMKTS:BCDA) are both small-cap medical companies, but which is the better investment?
We are comparing TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) on their risk, analyst ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and MannKind Corporation (NASDAQ:MNKD) are Biotechnology companies, competing one another.
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and UroGen Pharma Ltd. (NASDAQ:URGN) are Biotechnology companies, competing one another.
TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Syndax Pharmaceuticals Inc. (NASDAQ:SNDX), both competing one another are Biotechnology ...
Analysts expect TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) to report $-0.38 EPS on February, 27.They anticipate $0.01 EPS change or 2.70 % from last ...
As Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and ContraVir Pharmaceuticals Inc. (NASDAQ:CTRV) are our subject to contrast ...
In October, James P. Allison and Tasuku Honjo won the Nobel Prize in medicine for their groundbreaking cancer research.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies.
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Xenon Pharmaceuticals Inc. (NASDAQ:XENE) are Biotechnology companies, competing one another ...
We are contrasting MediWound Ltd. (NASDAQ:MDWD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) on their profitability, analyst recommendations, risk ...
Tracon Pharmaceuticals Inc (NASDAQ:TCON) had a decrease of its shares shorted by 6.73%. FINRA issued in January TCON's total 134400 shares shorted.
TRACON Pharmaceuticals Inc (NASDAQ:TCON) rose 17.4% during mid-day trading on Thursday . The stock traded as high as $1.20 and last traded at $1.06.
Angiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
Any cancer treatment can involve blood, sweat and tears, but did you know you could save the blood? My genetic counselor told me that saving a blood sample ...
The Ken Pribil Jr. Foundation recently made its fifth annual Sarcoma Research Grant in the amount of $15,000 to support targeted angiosarcoma cancer ...
The Ken Pribil Jr. Foundation recently made its fifth annual Sarcoma Research Grant in the amount of $15,000 to support targeted angiosarcoma cancer ...
We're having a snowy weekend here in Northeast Ohio. I can hear my husband shoveling the snow off the walkway to our house. When he's done shoveling, ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and TG Therapeutics Inc. (NASDAQ:TGTX) are Biotechnology companies, competing one another.
As Biotechnology companies, Agios Pharmaceuticals Inc. (NASDAQ:AGIO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our subject to contrast.
Three Confirmed Partial Responses by RECIST and> 50% Reductions of Alpha Fetoprotein in Half of Patients Treated to Date with Combination of TRC105.
TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted.
Three Confirmed Partial Responses (20%) by RECIST and > 50% Reductions of Alpha Fetoprotein in Half of Patients Treated to Date with Combination of ...
As Biotechnology companies, GTx Inc. (NASDAQ:GTXI) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our subject to compare. And more specifically ...
We are contrasting TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Flex Pharma Inc. (NASDAQ:FLKS) on their institutional ownership, profitability, risk, ...
Both TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Innoviva Inc. (NASDAQ:INVA) are Biotechnology companies, competing one another. We will ...
As Biotechnology companies, Applied Genetic Technologies Corporation (NASDAQ:AGTC) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our ...
Both MyoKardia Inc. (NASDAQ:MYOK) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are Biotechnology companies, competing one another. We will ...
Ardevora Asset Management Llp increased Ralph Lauren Corp (RL) stake by 6.67% reported in 2018Q3 SEC filing. Ardevora Asset Management Llp acquired ...
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded down 9.4% during mid-day trading on Friday . The company traded as low as $0.91 and last ...
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares traded down 9.4% during mid-day trading on Friday . The company traded as low as $0.91 and last ...
TRACON Pharmaceuticals (NASDAQ:TCON) had its price objective decreased by equities research analysts at BTIG Research to $9.00 in a research note ...
TRACON Pharmaceuticals (NASDAQ:TCON) had its target price dropped by investment analysts at BTIG Research to $9.00 in a research note issued to ...
TRACON Pharmaceuticals Inc (NASDAQ:TCON) shares were up 17.4% during mid-day trading on Thursday . The stock traded as high as $1.20 and last traded ...
TRACON Pharmaceuticals (NASDAQ:TCON) had its target price lowered by research analysts at BTIG Research to $9.00 in a research note issued on ...
It was showed a decrease on Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s short interest with 6.73%. FINRA issued in January TCON's total 134400 short ...
Global Orphan Drugs Market is expected to garner $169 billion from $106 billion and register a CAGR of 6.8% during the forecast period, 2016-2022. Orphan ...